Remove 2021 Remove Hospitals Remove Omnicell
article thumbnail

Welcome to Omnicell Illuminate 2021

Omnicell

The pandemic has elevated the role of pharmacists—who have been vital in setting up temporary COVID-19 units and field hospitals, particularly with patients on ventilators. For nearly 30 years, Omnicell has been dedicated to driving change, and the pace of advancement in this industry is dramatically accelerating.

article thumbnail

Driving Pharmacy Value Through Robotics and Connected Technology

Omnicell

Dennis Wright, Senior Director, Product Marketing, Omnicell As health systems navigate escalating staff shortages and increasingly complex drug therapies, the need for a high-performing pharmacy has never been greater. billion in 2021 and is anticipated to increase another 6 percent this year.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The High Cost of Nursing Turnover

Omnicell

Kristine Shepherd, MSN, RN Nurse Consultant, Omnicell Point of Care Solutions $7.1 That’s what an average US hospital loses due to nursing turnover, according to the 2022 NSI National Health Care Retention & RN Staffing Report. million annually. For many nurses, direct patient care is at the heart of meaningful work.

article thumbnail

Omnicell and Fresenius Kabi Join Forces to Improve Controlled Substance Management

Omnicell

Tara Plappert Product Marketing Manager Hospitals and clinics face a significant challenge when dealing with controlled substances. More concerning, on average, it takes about 22 months for a hospital to discover an incident of diversion. And according to the 2019 Drug Diversion Digest , 47.2

article thumbnail

Reducing Drug Spend with IV Robotic Services

Omnicell

Director, Central Pharmacy Product Marketing, Omnicell IV automation technology combined with robust expert services is a game-changer for reducing drug spend while enhancing patient safety. Still, many hospital pharmacies continue to struggle to improve safety and efficiency in their sterile compounding operations. Dennis Wright Sr.

article thumbnail

Federal 340B Drug Pricing Program – An Industry Update and Mitigation Strategies Relative to Recent Challenges

Omnicell

Jeff Spencer Senior Director, 340B Sales and Account Management, Omnicell Since its inception 30 years ago, the 340B Drug Pricing Program has helped non-profit healthcare organizations expand services for their communities. Hospitals and clinics are eligible based on defined criteria. So, how does 340B ESP work?

article thumbnail

Addressing Specialty Pharmacy Adherence Challenges Head On

Omnicell

Sarah Kester, PharmD Pharmaceutical Program Manager, Omnicell Specialty Pharmacy Services Medication non-adherence is a crippling problem in healthcare today, causing unnecessary hospitalizations and escalating costs. This problem is especially prevalent for patients receiving long-term therapy for chronic conditions.